Loading...
Drug Companies vs. Brazil: The threat to public health
Citations
Altmetric:
Titre
Publication date
2001-05-01
Document type
Briefing paper
Pages
17
Author(s)
Advisors
Editor(s)
Other Contributors
Affiliation
ePub Date
Submitted date
Subject
Local subject classification
MeSH
Keywords
Country
Collections
Files
Loading...
English paper
Adobe PDF, 152.21 KB
Loading...
Portugese paper
Adobe PDF, 171.96 KB
Loading...
Spanish paper
Adobe PDF, 159.73 KB
Description
The access of impoverished Brazilians to essential medicines, including those required for treatment of HIV/AIDS, is under threat. International pharmaceutical firms, with the backing of the United States government, are trying to ensure that Brazil has to buy the expensive patented drugs that they manufacture, rather than have access to the cheaper generic drugs that the country is making for itself or could buy from countries such as India. The companies are also resisting tighter price controls on their products. Oxfam believes that higher prices for medicines will cause unnecessary sickness and death among the sixty million Brazilians living in poverty, and calls on the US government and the companies to stop putting pressure on Brazil to change its policies.
Language
English
Spanish
Portuguese
Spanish
Portuguese
Other Titles
Abstract
Citation
Publisher(s)
Journal
Journal Theme
Volume
Issue
Research Unit
DOI
Table of contents
Series
ISSN
EISSN
ISBN
978-1-84814-323-4